Oxcarbazepine treatment of posttraumatic stress disorder [3]

Canadian Journal of Psychiatry

Volumn 47, Issue 10, 2002, Pages 973-974

  Berigan, Timothy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; OXCARBAZEPINE;

ADULT; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; HUMAN; HYPONATREMIA; LETTER; MALE; NAUSEA; POSTTRAUMATIC STRESS DISORDER; SOMNOLENCE; VERTIGO; VOMITING;

EID: 0036989095     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370204701014     Document Type: Letter

References (12)

1. Nutt DJ. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry 2000; 61 (Suppl 5):24-9.
2. Keck PE, McElroy SL, Friedman LM. Valproate and carbamezapine in the treatment of panic and posttraumatic stress disorder, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 1992; 12 (Suppl):36S-41S.
3. Lipper S, Davidson JRT, Grady TA, Edinger JD, Hammett ER, Mahomey SI, and others. Preliminary study of carbamezapine in post-traumatic stress disorder. Psychosomatics 1986;27:849-54.
4. Wolf ME, Alvai A, Mosnaim AD. Posttraumatic stress disorder in Vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamezapine. Biol Psychiatry 1988;23:642-4.
5. Stewart JT, Bartucci RJ. Posttraumatic stress disorder and partial complex seizures. Am J Psychiatry 1986;143:113-4.
6. Grant SM, Faulds D. Oxcarbezapine: a review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 1992;43:873-88.
7. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
8. National Institute of Mental Health. CGI: Clinical Global Impression. In: Guy W, Bonato RR, editors. Manual for the ECDEU Assessment Battery. Revised 2nd ed. Chevy Chase (MD): National Institute of Mental Health; 1970. 12.1-12.6.
9. McAuley JW, Biederman TS, Smith JC, Moore JL. Newer therapies in the drug treatment of epilepsy. Ann Pharmacother 2002;36:119-28.
10. Fisher RS. Epilepsy. In: Enna SJ, Coyle JT, editors. Pharmacologic management of neurological and psychiatric disorders. New York: McGraw Hill; 1998. p 459-503.
11. Barcs G, Walker EB, Elger CE, Scarmelli A, Stefan H, Sturm Y, and others. Oxcarbazepine placebo-controlled dose ranging trial in refractory partial epilepsy. Epilepsia 2000;41:1597-607.
12. Novartis. Trileptal package insert. East Hanover (NJ): Novartis; 2001.